Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001818382-25-000076
Filing Date
2025-05-13
Accepted
2025-05-13 17:11:17
Documents
87
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q huma-20250331.htm   iXBRL 10-Q 1307973
2 EX-31.1 huma-20250331x10qxex311.htm EX-31.1 10679
3 EX-31.2 huma-20250331x10qxex312.htm EX-31.2 10703
4 EX-32.1 huma-20250331x10qxex321.htm EX-32.1 4869
5 EX-32.2 huma-20250331x10qxex322.htm EX-32.2 4877
  Complete submission text file 0001818382-25-000076.txt   8827465

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT huma-20250331.xsd EX-101.SCH 70981
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT huma-20250331_cal.xml EX-101.CAL 58721
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT huma-20250331_def.xml EX-101.DEF 443897
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT huma-20250331_lab.xml EX-101.LAB 777342
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT huma-20250331_pre.xml EX-101.PRE 622753
90 EXTRACTED XBRL INSTANCE DOCUMENT huma-20250331_htm.xml XML 1279908
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

EIN.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39532 | Film No.: 25941302
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)